Meridian Bioscience Inc. (VIVO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Meridian Bioscience Inc.

    NASDAQ: VIVO · Real-Time Price · USD
    33.97
    0.00 (0.00%)
    At close: Jan 30, 2023, 10:00 PM

    Meridian Bioscience Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Sep 30, 2022 Sep 30, 2021
    Revenue
    		 333.02M 317.9M
    Cost of Revenue
    		 144.66M 116.75M
    Gross Profit
    		 188.36M 201.15M
    Operating Income
    		 55.51M 93.03M
    Interest Income
    		 17K n/a
    Pretax Income
    		 54.32M 90.45M
    Net Income
    		 42.46M 71.41M
    Selling & General & Admin
    		 88.42M 79.12M
    Research & Development
    		 24.34M 23.91M
    Other Expenses
    		 -350K 4.6M
    Operating Expenses
    		 112.41M 107.63M
    Interest Expense
    		 1.19M 1.88M
    Selling & Marketing Expenses
    		 31.27M 26.78M
    Cost & Expenses
    		 257.07M 224.38M
    Income Tax Expense
    		 11.86M 19.04M
    Shares Outstanding (Basic)
    		 44.01M 44.01M
    Shares Outstanding (Diluted)
    		 44.01M 44.01M
    EPS (Basic)
    		 0.96 1.62
    EPS (Diluted)
    		 0.96 1.62
    EBITDA
    		 72.02M 107.61M
    EBIT
    		 55.51M 92.33M
    Depreciation & Amortization
    		 16.51M 15.29M

    Add to Watchlist